BackBiostar Pharmaceuticals Overview

Biostar Pharmaceuticals Receivables

Biostar Pharmaceuticals's receivables is $460K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$461031.00
↓ 92.43% YoYΔ $-5.63M vs prior year quarter

Peer average

Loading

Biostar Pharmaceuticals Receivables History

Loading

Biostar Pharmaceuticals vs. peers: Receivables Comparison

Loading

Biostar Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Biostar Pharmaceuticals (BSPM) FAQ

The latest receivables for BSPM is $460K as of September 2017. That compares with $6.1M in the prior-year period — down 92.4% year over year. Investors often review this figure alongside Biostar Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, BSPM's receivables moved from $6.1M to $460K — a 92.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biostar Pharmaceuticals's operating scale or balance-sheet position.

A receivables figure of $460K for BSPM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BSPM's receivables ($460K), review year-over-year change from $6.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.